BG-4, a novel bioactive peptide from momordica charantia, inhibits lipopolysaccharide-induced inflammation in THP-1 human macrophages. (Q52588253)
Jump to navigation
Jump to search
scientific article published on 19 March 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | BG-4, a novel bioactive peptide from momordica charantia, inhibits lipopolysaccharide-induced inflammation in THP-1 human macrophages. |
scientific article published on 19 March 2018 |
Statements
BG-4, a novel bioactive peptide from momordica charantia, inhibits lipopolysaccharide-induced inflammation in THP-1 human macrophages. (English)
momordica charantia
1 reference
Lynsey D Jones
Philipus Pangloli
Hari B Krishnan
19 March 2018
42
226-232